Oral arsenic trioxide for treating acute promyelocytic leukaemia: Implications for its worldwide epidemiology and beyond

This account describes how orally administered Arsenic-trioxide (ATO) therapy influences the epidemiology of acute promyelocytic leukaemia (APL), and how the experience that ensued may expand the indications for oral ATO as a treatment for diseases/disorders other than APL. Over the last two decades...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumana, Cyrus R., Kwong, Yok-Lam, Gill, Harinder
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744132/
https://www.ncbi.nlm.nih.gov/pubmed/36518307
http://dx.doi.org/10.3389/fonc.2022.1026478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744132/
https://www.ncbi.nlm.nih.gov/pubmed/36518307
http://dx.doi.org/10.3389/fonc.2022.1026478

Ejemplares similares